SMS Co., Ltd. (SMSSY)
OTCMKTS · Delayed Price · Currency is USD
5.44
0.00 (0.00%)
At close: Sep 5, 2025
SMS Co., Ltd. Revenue
SMS Co., Ltd. had revenue of 18.67B JPY in the quarter ending June 30, 2025, with 7.15% growth. This brings the company's revenue in the last twelve months to 62.20B, up 10.66% year-over-year. In the fiscal year ending March 31, 2025, SMS Co., Ltd. had annual revenue of 60.95B with 12.93% growth.
Revenue (ttm)
62.20B JPY
Revenue Growth
+10.66%
P/S Ratio
2.08
Revenue / Employee
13.74M JPY
Employees
4,528
Market Cap
894.93M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 60.95B | 6.98B | 12.93% |
Mar 31, 2024 | 53.97B | 8.31B | 18.19% |
Mar 31, 2023 | 45.67B | 6.77B | 17.40% |
Mar 31, 2022 | 38.90B | 2.94B | 8.17% |
Mar 31, 2021 | 35.96B | 820.00M | 2.33% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
HealthLynked | 2.58M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |